Business NewsPR NewsWire • Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H1 2015

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H1 2015

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H1 2015

NEW YORK, March 9, 2015 /PRNewswire/ -- SummaryGlobal Markets Direct's, 'Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H1 2015', provides an overview of the Mucopolysaccharidosis I (MPS I) (Hurler Syndrome)'s therapeutic pipeline.This report provides comprehensive...

View More : http://www.prnewswire.com/news-releases/mucopolysaccharidosis-i-mps-i-hurler-syndrome---pipeline-review-h1-2015-30004739...
Releted News by prnewswire
Genedata Expressionist® Ready for Deployment in Regulated Environments
Gerencianet lanza una aplicación para comprar y vender a través de Instagram
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H1 2015
TCL Corporation annonce ses résultats de l'exercice 2014, avec des chiffres d'affaires et des bénéfices battant tous les records
Global Healthcare Analytics Market - Growth, Trends & Forecast To 2020: Market is Poised to Reach $23.8 Billion by the End of 2020